THE CLINICAL SCENARIO
=====================

A 42-year-old woman with a body mass index (BMI) of 51.2 kg/m^2^ was referred to the respiratory clinic for investigation of progressive breathlessness which had worsened in the past 5 years-her score on the modified Medical Research Council scale at presentation was 3 (i.e., she reported having to stop for breath after walking for only a few minutes). She was a never smoker, and her dyspnea had been mainly attributed to obesity.

THE UNDERLYING PHYSIOLOGY
=========================

Spirometry showed a mild-to-moderate, proportional reduction in FEV~1~ and in FVC, which resulted in a preserved FEV~1~/FVC ratio ([Figure 1](#f1){ref-type="fig"}A). According to the latest American Thoracic Society/European Respiratory Society algorithm for the interpretation of pulmonary function tests, the decision to label this pattern as restrictive or obstructive depends on measurements of TLC.[@B1] The authors of that document also stated that, although FVC is often used in the abovementioned ratio, it is preferable to use the largest available VC, whether it is that obtained during inspiration, that obtained during slow expiration, or that obtained during forced expiration. However, the FVC may underestimate the "true" maximal VC due to early closure of the small airways at low lung volumes. That is especially true in the presence of increased small airway compressibility or collapsibility.[@B2] It follows that a "pseudo-normal" FEV~1~/FVC ratio might occur in patients with obstructive ventilatory disorder, provided there is a large difference between the slow vital capacity (SVC) and the FVC. Nevertheless, there are few reference values for SVC. It is possible that FVC decreases with aging at a faster rate than does SVC[@B3]; that is, a low FEV~1~/SVC ratio might simply reflect the physiological effects of senescence. Therefore, there are potential advantages and disadvantages to using SVC rather than FVC in the FEV~1~/VC ratio. A large recent study analyzing 13,893 consecutive adults with preserved FEV~1~/FVC ratios and TLCs shed new light on this controversial issue.[@B4] The authors reported the following: one in every five subjects presented with a low FEV~1~/SVC ratio ("discordant" subjects); most subjects showing obstruction only according to the FEV~1~/SVC ratio were highly likely to have airway disease and dysfunction according to a cluster of clinical and physiological variables; regardless of the gender of the subject, the variables age \< 60 years, BMI \> 30 kg/m^2^, and FEV~1~ \> 70% of the predicted value were all associated with "discordance"; and "discordant" subjects ≥ 70 years of age showed no other evidence of airway disease or dysfunction.

Figure 1Baseline FVC (panel A) and SVC (panel B). Flow-volume loops before and after acute administration of albuterol (blue and red lines, respectively) are shown in panel C, as are the post-bronchodilator values and variations (∆) in relation to the baseline values. BD: bronchodilator; LLN: lower limit of normality; ULN: upper limit of normality; and % pred: percentage of the predicted value.

OVERVIEW
========

Due to time and operational constraints, most pulmonary function testing laboratories in primary care still perform only the forced expiratory maneuver.[@B5] Given the results of the abovementioned study,[@B4] adding the SVC maneuver may represent a simple strategy to reveal an obstructive ventilatory defect that was missed by determination of the FEV~1~/FVC ratio in a non-elderly (\< 60 year-old) obese subject with a high pre-test probability of airway disease. A positive flow or volume response to inhaled bronchodilator administration might also prove useful to reveal airflow limitation in these subjects. Considering the risk of overdiagnosis of obstruction in the elderly (individuals \> 70 years of age), it seems prudent to avoid using SVC in the FEV~1~/VC ratio in this subpopulation. A case-by-case approach should be applied in subjects 60-70 years of age.

OUTCOME
=======

In the case presented here, involving a middle-aged obese woman with a preserved FEV~1~/FVC ratio ([Figure 1](#f1){ref-type="fig"}A), airflow limitation was detected on the basis of the SVC ([Figure 1](#f1){ref-type="fig"}B). A positive volume response to inhaled albuterol further supported the diagnosis of an obstructive ventilatory defect ([Figure 1](#f1){ref-type="fig"}C). In fact, the patient reported a noticeable improvement in her shortness of breath after starting twice-daily treatment with inhaled formoterol plus budesonide.
